1. Introduction {#sec1}
===============

Depression often complicates epilepsy as it is the most frequent psychiatric disorder associated with epilepsy \[[@B1]\]. The abnormal brain neuronal activity that causes epileptic seizures can also lead to depressive moods, and the stress of living with a chronic condition can worsen feelings of anxiety and depression \[[@B2]--[@B4]\]. Depressed patients are often not motivated and thus making effective management of epilepsy difficult \[[@B5]\]. Depression could be reactive to epilepsy where it is a form of negative feedback to the ongoing seizure disorder \[[@B6]\]. Sad feeling that is occasional is common and not strange to human beings but what separates it from a disease condition is the intensity, which is higher and for longer periods of time in depression and sometimes without any apparent reason \[[@B7]--[@B9]\]. Depression in epilepsy could also be before, during, or after seizure and it may not even have any relationship to the seizure.

However, depression in patients with epilepsy is underdiagnosed even among mental health professionals. The reasons for this include inadequate evaluation of and poor attention to the psychological states of patients with epilepsy by the treating physician. Furthermore, the management of patients with epilepsy by a large number of non-mental health professionals who do not have the expertise in eliciting these depressive symptoms portends a worse prognosis. The increasing prevalence of depression worldwide and the World Health Organization\'s (WHO) postulate of depression being the leading cause of death by 2020 makes this more worrisome among this subpopulation.

Evidence-based findings and knowledge of the prevalence of depression including the factors associated with its occurrence among patients with epilepsy will enhance the management of these patients by mental health professionals. This knowledge gap will also be reduced among non-mental health professionals that also treat epilepsy. It is believed that these findings will be influenced by the sociocultural background of the study setting and these are factors that will be useful to governmental/nongovernmental organizations in planning healthcare interventions and implementing policies for patients with epilepsy.

2. Aim {#sec2}
======

To determine sociodemographic and clinical factors associated with the occurrence of depression among patients with epilepsy in Sokoto, Northwest Nigeria.

2.1. Objectives {#sec2.1}
---------------

To determine the prevalence of depression among patients living with epilepsy and attending the Federal Neuropsychiatric Hospital, Kware, Sokoto State, NigeriaTo examine the sociodemographic and clinical factors that are associated with the occurrence of depression among patients with epilepsy in the Federal Neuropsychiatric Hospital, Kware, Sokoto State, Nigeria

3. Methodology {#sec3}
==============

Ethical approval for this study was sought and obtained from the Ethical Committee of the Federal Neuropsychiatric Hospital, Kware, Sokoto, where the study was carried out. The sample size of 400 was derived using the sample size estimate for proportion \[[@B10], [@B11]\]. As the outpatient departments are combined for all neuropsychiatric disorders, those with diagnosed epilepsy for at least 6 months prior to their participation were recruited consecutively after seeking their informed consent. The diagnostic criterion used to define epilepsy was the International Classification of Diseases (ICD-10) codes for epilepsy and seizures. Participants were examined with the proforma questionnaire designed by the researchers using relevant literatures. Data on their sociodemographic characteristics and clinical variables such as frequency of seizure, age at illness onset, previous substance use disorder, presence of recurrent/uncontrolled seizure, current use of antiepileptic(s), previous hospital admission on account of seizure, fear of having seizure (assessed in three domains (no fear/rarely/always)), description of family social support (assessed in three domains (reduced/no change/increased)), family history of mental illness, etc. were obtained and analyzed. Participants were initially screened with General Health Questionnaire GHQ-28 (a self-administered questionnaire used to screen for the presence of mental illness). After administration of the GHQ-28, the participants were then administered the depression module of the Composite International Diagnostic Interview (CIDI) (a fully structured validated instrument for the assessment of psychiatric disorders). This was used to diagnose depressive disorder in the participants. It would have been difficult to reschedule these patients for another day for the administration of the CIDI. This is because quite a number of them came from afar, and they do not have access to mobile phone for ease of contact. The GHQ and CIDI were administered by one of the researchers who was trained by a CIDI certified trainer. The following inclusion criteria were observed for the study: (1) Participants were between 18 and 60 years. (2) Patients that were diagnosed with epilepsy as defined by ICD-10 codes for epilepsy and seizures. (3) All participants with clinical diagnosis of epilepsy were required to have done electroencephalography (EEG). They were recruited, whether their EEG results were positive or negative. (4) Patients that had been diagnosed and stable with epilepsy for at least 6 months.

3.1. Study Design {#sec3.1}
-----------------

It was a descriptive, cross-sectional, hospital-based study.

3.2. Data Analysis {#sec3.2}
------------------

Data was analyzed using Statistical Package for Social Sciences (SPSS) version 20 software. Data were presented in tables to highlight the demographic, psychological, and clinical variables of concern, and their relationship with depression means and standard deviations (S.D) was used for descriptive statistics while the means of continuous data were compared using *t*-test. The chi-square (*χ*^2^) test was used to compare categorical variables, and logistic regression was used to determine the predictors of depression. All tests of significance were set at *p* \< 0.05.

4. Results {#sec4}
==========

4.1. Sociodemographic Characteristics of Participants with Depression {#sec4.1}
---------------------------------------------------------------------

A total of 400 participants took part in the study of which 35 (8.8%) were diagnosed as having depression. Non-Hausas were significantly more likely to be depressed when compared to Hausas. The other sociodemographic findings are as shown in [Table 1](#tab1){ref-type="table"}.

4.2. Psychological Characteristics of Participants in Both Groups (Depressed and Nondepressed) {#sec4.2}
----------------------------------------------------------------------------------------------

Fear of having seizure, seizure worry, change in lifestyle, and family history of mental illness were associated with depression among the participants, see [Table 2](#tab2){ref-type="table"} for full details.

4.3. Clinical Characteristics of Participants in Both Groups (Depressed and Nondepressed) {#sec4.3}
-----------------------------------------------------------------------------------------

[Table 3](#tab3){ref-type="table"} illustrates the clinical variables that were associated with depression in those with epilepsy. The presence of physical complications, lower mean duration since last seizure episode, and GHQ caseness were associated with depression.

4.4. Multivariate Logistic Regressions for the Predictors of Depression in the Study Groups {#sec4.4}
-------------------------------------------------------------------------------------------

Logistic regression analysis was done for the association between the significant sociodemographic/clinical factors and depression. Only ethnicity, family history of mental illness, and GHQ caseness remained as predictors of depression, see [Table 4](#tab4){ref-type="table"}.

5. Discussion {#sec5}
=============

5.1. Sociodemographic Variables {#sec5.1}
-------------------------------

The sociodemographic findings are similar to other studies done in some northern states of Nigeria \[[@B12]\]. The finding of the ethnic minorities being more likely to become depressed when compared to the major ethnic group is in keeping with an earlier study in Sokoto, Nigeria \[[@B13]\]. They reported that the major ethnic groups had less rate of depression when compared to the minority ethnic groups. Other studies had also buttressed this fact of ethnic minorities and depression proneness \[[@B14]--[@B16]\]. These studies concluded that ethnic minorities lack social support among some other disadvantages. The other reasons given were that ethnic minorities experience barriers to good treatment care, they have limited knowledge, and they underutilize treatment avenues.

There was also the possibility of ethnic minorities facing lots of stress as a result of their migration which may precipitate mental illness \[[@B17]\].

5.2. Depression among the Patients with Epilepsy {#sec5.2}
------------------------------------------------

There has been much variability in the reported rate of occurrence of depression among seizure patients by different studies. This varied from 5% to as high as 70%. The 8.8% that was reported in this study is in keeping with the observations of studies that have a higher number of patients with controlled seizure (especially due to medications). They often report a prevalence that is equivalent to the ones seen in the general population \[[@B18], [@B19]\].

However, a population-based, case-control study found that depression was about 3.7 times more likely to occur before initial (first) seizure than subsequently \[[@B20]\]. A number of reasons may explain the pathophysiology and this dual-directional relationship between epilepsy and depression. Generally, abnormal activity of neurotransmitters especially serotonin, noradrenalin, dopamine, GABA, and glutamate and neuropathological changes in the frontotemporal regions with 5-HT1A reduction and dysfunction of the hypothalamic---pituitary---adrenal axis have been implicated in the occurrence of depression in epilepsy \[[@B21]\].

Depression is a leading cause of disability worldwide and is a major contributor to the overall global burden of disease \[[@B22]\]. This portends a poorer outcome and increased cost of treatment for epilepsy in individuals with untreated comorbid depression.

5.3. Factors Associated with Depression in the Patients with Epilepsy {#sec5.3}
---------------------------------------------------------------------

Epileptic patients that were of the minority ethnic group and also those that had a family history of psychiatric illness were more likely to be depressed. The association with the ethnic minority is similar to the findings of a similar study, where increased rate of depression in ethnic minorities was found \[[@B23]\]. Another study which aimed among other things, to determine the demographic correlates of depression among patients with epilepsy reported that ethnic minority and being elderly were the predictors of having depression \[[@B24]\]. Individuals from a minority ethnic group may be subjected to discrimination and culture shock, especially in immigrant ethnic minorities. However, it has been reported that immigration alone does not cause serious problem but it becomes a very potent factor in mental illness when combined with other risk factors like unemployment, language difficulties, and the stress of migration \[[@B25]\]. All these may act as precipitants to the person that is already having a genetic loading evident by a positive family history. Majority of participants that had depression also had a family history of mental illness; this was similar to what was found in a similar study in Nigeria \[[@B26]\]. In another study, it was reported that a family history of depression was quite common among depressed patients with epilepsy \[[@B13]\]. It shows that there is an element of genetic association in those that are vulnerable to depression which may be aggravated by the epilepsy.

In a review of studies on psychiatric disorders and epilepsy, personal and/or family psychiatric history was reported to be associated with an increased risk of nonpsychiatric and psychiatric adverse effects to antiepileptic drugs (AEDs) \[[@B27]\]. Depression has been particularly associated with the use of barbiturates, vigabatrin, topiramate, and felbamate in patients being treated for epilepsy. The identification of patients who are more at risk of developing depression during AED therapy is therefore crucial in their management. A family history of depression is an important risk factor and should be ascertained before institution of treatment.

6. Conclusion {#sec6}
=============

The rate of occurrence of depression in patients with epilepsy in this study is relatively high when compared to reported rates of other comorbid psychopathologies like anxiety disorders in people with seizure disorders. Mental health professionals should thus consider the regular assessment of depression in patients with epilepsy, especially those who have a family history of psychiatric disorder. This will enhance the early detection of possible comorbid depression among them. Also, patients with epilepsy of the ethnic minorities should be regularly assessed for sociodemographic factors that are negatively impacting their quality of life. Social interventions should be instituted for them when these stressors are identified.

Data Availability
=================

The data used to support the findings of this study are available from the corresponding author upon request.

Additional Points
=================

*Limitations*. The use of self-reported questionnaires could lead to bias as most of the questions were about what had happened in the past. The participants might have forgotten the actual details of events, and due to the fact that cognitive decline is a common occurrence in epilepsy, the data collected from participants are prone to recall bias. Also, the study was a cross-sectional descriptive one and thus may not be sensitive to changes in the levels of the measurements over time. This study focused on patients in the hospital setting; therefore, the findings may not be representative of what obtains in the community.
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###### 

Comparison of the sociodemographic characteristics of the depressed and nondepressed study groups (*n* = 400).

  Variable                            Depression group *n* (%) (*N* = 35)   No depression group *n* (*N* = 365)   *Χ* ^2^/*t*      D. F   *p* value
  ----------------------------------- ------------------------------------- ------------------------------------- ---------------- ------ -----------
  Age in years                                                                                                                            
  Mean (S.D)                          30.37 (8.35)                          28.60 (9.34)                          *t* = −0.52      398    0.60
  Gender                                                                                                                                  
   Male                               19 (7.1)                              247                                                           
   Female                             16 (11.9)                             118                                   *Χ* ^2^ = 2.57   1      0.08
  Occupation by                                                                                                                           
  Social class                        13 (8.2)                              146                                                           
   Unemployed/social class (others)   22 (9.1)                              219                                   *Χ* ^2^ = 0.11   1      0.86
  Marital status                                                                                                                          
   Married                            15 (8.6)                              159                                                           
   Others                             20 (8.8)                              206                                   *Χ* ^2^ = 0.01   1      0.94
  Educational status                                                                                                                      
   Western                            10 (6.6)                              141                                                           
   Education/NIL                      25 (10.0)                             224                                   *Χ* ^2^ = 1.38   1      0.24
  Ethnicity                                                                                                                               
   Hausa                              26 (7.4)                              327                                   *Χ* ^2^ = 7.21   1      0.01
   Others                             9 (10.0)                              38                                                            
  Religion                                                                                                                                
   Islam                              34 (8.6)                              360                                                           
   Christianity                       1 (16.7)                              5                                     *Χ* ^2^ = 0.48   1      0.43

###### 

Comparison of the psychological characteristics of the study participants in the depressed and nondepressed groups (*n* = 400).

  Variables                          Depression group *n* (%) (*N* = 35)   No depression *n* (*N* = 365)   *X* ^2^   D. F   *p* value
  ---------------------------------- ------------------------------------- ------------------------------- --------- ------ -----------
  Fear of having seizure                                                                                                    
   No                                20 (57.1)                             290                                              
   Yes                               15 (42.9)                             75                              9.12      1      \<0.01
  Seizure worry                                                                                                             
   No                                10 (28.6)                             210                                              
   Yes                               25 (71.4)                             155                             10.84     1      \<0.01
  Change in lifestyle                                                                                                       
   No                                6 (17.1)                              210                                              
   Yes                               29 (82.9)                             155                             20.98     1      \<0.001
  Social support                                                                                                            
   Reduced                           6 (17.1)                              42                                               
   No change                         15 (42.9)                             165                             0.97      2      0.62
   Increased                         14 (40.0)                             158                                              
  Family history of mental illness                                                                                          
   No                                20 (57.1)                             292                                              
   Yes                               15 (42.9)                             73                              9.72      1      \<0.01

###### 

Comparison of the clinical characteristics of the study subjects in the depressed and nondepressed study groups (*n* = 400).

  Variables                           Depression group *n* (%) (*N* = 35)   No depression group *n* (*N* = 365)   *Χ* ^2^/*t*         D. F    *p* value
  ----------------------------------- ------------------------------------- ------------------------------------- ------------------- ------- -----------
  Seizure diagnosis                                                                                                                           
   Grand mal                          25 (8.3)                              277                                                               
   Others                             10 (10.2)                             88                                    *Χ* ^2^ = 0.34      1       0.56
  Age at seizure onset (yrs)                                                                                                                  
   0--19                              22 (17.6%)                            240                                                               
   20--39                             13 (15.8%)                            115                                                               
   40--59                             0                                     10                                                                
   ≥50                                                                                                                                        
  Range: 1--59                                                                                                                                
  Mean (S.D)                          14.83 (8.50)                          16.57 (10.70)                         *t* = 0.93          398     0.35
  Duration of seizure (yrs)                                                                                                                   
   0--19.9                            24 (7.3%)                             304                                                               
   20.0-39.9                          9 (13.4%)                             58                                                                
   40.0-59.9                          24 (40%)                              3                                                                 
  Range: 0.17-42.50                                                                                                                           
  Mean (S.D)                          15.22 (11.27)                         11.94 (8.15)                          *t* = −1.68         37.48   0.10
  Duration since last seizure(days)                                                                                                           
   0--100                             30 (10.5%)                            256                                                               
   ≥101                               5 (4.4%)                              109                                                               
  Range: 1--5475                                                                                                                              
  Mean (S.D)                          69.49 (155.20)                        223.15 (573.41)                       *t* = 2.41          45.62   0.02
  Physical complications                                                                                                                      
   No                                 20 (6.3)                              298                                                               
   Yes                                15 (18.3)                             67                                    *Χ* ^2^ = 11.76     1       \<0.01
  Seizure in the last one month                                                                                                               
   No                                 12 (6.2)                              183                                                               
   Yes                                23 (11.2)                             182                                   *Χ* ^2^ = 3.21      1       0.07
  Psychoactive drug prior seizure                                                                                                             
   No                                 32 (8.8)                              333                                                               
   Yes                                3 (8.6)                               32                                    *Χ* ^2^ = 0.002     1       0.06
  Current hard drug use                                                                                                                       
   No                                 34 (9.2)                              337                                                               
   Yes                                1 (3.4)                               28                                    *Χ* ^2^ = 1.10      1       0.25
  Seizure drug                                                                                                                                
   Monodrug                           29 (8.0)                              332                                                               
   Multiple drugs                     6 (1.8)                               33                                    *Χ* ^2^ = 2.38      1       0.13
  Medical disorder                                                                                                                            
   No                                 30 (8.3)                              330                                                               
   Yes                                5 (12.5)                              35                                    *Χ* ^2^ = 0.783     1       0.26
  Previous hospitalization                                                                                                                    
   No                                 32 (9.0)                              323                                                               
   Yes                                3 (6.7)                               42                                    *Χ* ^2^ = 0.276     1       0.43
  Maternal pregnancy complications                                                                                                            
   No                                 25 (8.8)                              260                                                               
   Yes                                1 (16.7)                              5                                     *Χ* ^2^ = 0.504     2       0.78
   Not reported                       9 (8.3)                               100                                                               
  Delivery-related complications                                                                                                              
   No                                 24 (8.5)                              258                                                               
   Yes                                2 (22.2)                              7                                     *Χ* ^2^ = 2.099     2       0.35
   Not reported                       9 (8.8)                               100                                                               
  GHQ caseness                                                                                                                                
   No                                 6 (1.8)                               323                                                               
   Yes                                29 (40.8)                             42                                    *Χ* ^2^ = 111.367   1       \<0.001
  EEG report                                                                                                                                  
   Negative                           17 (10.4)                             146                                                               
   Positive                           18 (7.6)                              219                                   *Χ* ^2^ = 0.972     1       0.32

###### 

Logistic regression analysis for the predictors of depression in the participants.

  Predictor variable                      *B*     *p* value     Exp(B)   Exp(B) (95% CI) lower   Exp(B) (95% CI) upper
  --------------------------------------- ------- ------------- -------- ----------------------- -----------------------
  Ethnicity                               -1.63   **\<0.01**    0.20     0.06                    0.64
  Fear of having seizure                  -0.33   0.49          0.71     0.28                    1.83
  Worry about seizure                     -0.27   0.60          0.76     0.29                    2.05
  Lifestyle change                        -0.47   0.42          0.62     0.20                    1.94
  Family history of psychiatric illness   -1.10   **0.02**      0.33     0.13                    0.84
  Duration since last seizure             0.000   0.83          0.94     0.77                    1.39
  Seizure complication                    0.67    0.17          1.98     0.77                    5.09
  GHQ caseness                            -3.33   **\<0.001**   0.04     0.01                    0.11
  Constant                                1.847   0.015         6.112                            
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